National Cancer Institute   U.S. National Institutes of Healthwww.cancer.gov
 
Home   |   Data & Statistics   |   Collaborations   |   Work with Us   |   Publications   |   About   |   Links

Performance Measures for 255,680 Diagnostic Mammography Examinations1 from 1996 to 2005 by Age & Time (Months) Since Previous Mammography

  PPV22 Abnormal Interpretation3
Age 40-44 22.7% 8.4%
<=15 months 18.8% 7.5%
16-20 months 19.3% 6.6%
21-27 months 26.1% 7.8%
28+ months 23.4% 8.7%
No previous mammography 30.2% 13.4%
Age 45-49 29.8% 8.4%
<=15 months 24.7% 7.5%
16-20 months 27.0% 6.9%
21-27 months 30.9% 7.6%
28+ months 36.8% 10.3%
No previous mammography 41.7% 17.9%
Age 50-54 34.0% 8.0%
<=15 months 28.6% 7.4%
16-20 months 37.6% 7.0%
21-27 months 37.3% 7.2%
28+ months 47.5% 10.2%
No previous mammography 46.3% 20.0%
Age 55-59 40.8% 7.8%
<=15 months 34.4% 6.9%
16-20 months 42.5% 6.8%
21-27 months 48.3% 8.1%
28+ months 54.9% 11.1%
No previous mammography 61.3% 27.0%
Age 60-64 43.3% 7.8%
<=15 months 37.1% 6.9%
16-20 months 45.3% 6.8%
21-27 months 43.9% 7.4%
28+ months 61.0% 11.6%
No previous mammography 65.1% 26.1%
Age 65-69 47.2% 8.2%
<=15 months 40.6% 6.9%
16-20 months 39.2% 7.2%
21-27 months 54.4% 9.6%
28+ months 66.3% 13.3%
No previous mammography 66.4% 28.6%
Age 70-74 51.3% 9.0%
<=15 months 41.6% 7.3%
16-20 months 51.8% 7.1%
21-27 months 58.8% 9.4%
28+ months 68.9% 16.5%
No previous mammography 74.7% 34.5%
Age 75-89 56.1% 11.0%
<=15 months 44.6% 7.6%
16-20 months 57.5% 8.1%
21-27 months 60.5% 11.5%
28+ months 69.0% 21.5%
No previous mammography 67.9% 41.3%

1 Diagnostic mammography examination: Mammography examinations indicated by the radiologist to be for evaluation of a breast problem.

2 PPV2 (Positive Predictive Value 2) = The percentage of examinations with a positive interpretation& that result in a tissue diagnosis of cancer§.

3 Abnormal interpretation = The percentage of examinations with a positive interpretation&.

§ Cancers = Examinations with a tissue diagnosis of ductal carcinoma in situ or invasive cancer within 30 days prior to or 1 year following the examination. Non-cancers = Examinations without a tissue diagnosis of ductal carcinoma in situ or invasive cancer within 30 days prior to or 1 year following the examination.

& Positive interpretation = BI-RADS category 0 or 3 with a recommendation for biopsy, 4, or 5. Negative interpretation = BI-RADS category 1, 2, 0 with no recommendation for biopsy nor additional imaging/work-up, or 3 with no recommendation for biopsy.

[Return to Diagnostic Performance]


National Cancer Institute Department of Health and Human Services National Institutes of Health USA.gov: The US government's official web portal Maintained by the Applied Research Program,
Division of Cancer Control and Population Sciences